Question

which of the following alerts might a technician see during the drug utilization evaluation (due) phase while processing a prescription?
change in prescription cost
out - of - state prescriber
change in generic manufacturer
allergy risk

Explanation:

Drug utilization evaluation (DUE) focuses on the appropriate use of medications. An allergy risk alert is relevant as it pertains to the safety and proper use of drugs during the DUE phase when processing a prescription. Changes in prescription cost, out - of - state prescriber, and change in generic manufacturer are not directly related to the core aspects of drug utilization evaluation which is centered around drug - related safety and appropriateness.

Answer:

Allergy risk